Antique Stock Broking has resumed coverage on four pharmaceutical stocks, favoring domestic-focused companies over those reliant on the US market. Analysts cite stronger earnings visibility and less pricing pressure in India as key advantages. The firm projects 10-11 per cent growth for the Indian pharma market, driven by base growth and new therapies. Torrent Pharmaceuticals is highlighted as a top pick, with Torrent Pharma, Concord Biotech rated 'buy', and Cipla and Dr Reddy's Labs rated 'hold'.